已收盘 08-21 16:00:00 美东时间
+9.560
+2.84%
今日重点评级关注:富瑞:维持ProMIS Neurosciences"买入"评级,目标价从69美元升至100美元;Benchmark:维持Cineverse"买入"评级,目标价从12美元升至14美元
08-17 13:37
ERock劲升11.42%;Keel Infrastructure Corp.大升6.55%;Marex Group上升5.21%
08-17 10:01
ERock大升8.31%;Keel Infrastructure Corp.大升7.69%;Marex Group大升5.21%
08-17 09:01
RBC Capital analyst Lisa Walter initiates coverage on Krystal Biotech (NASDAQ:KRYS) with a Outperform rating and announces Price Target of $400.
08-14 22:15
Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY) was in merger talks with AstraZeneca (AZN), a development that was later denied by...
08-09 03:28
今日重点评级关注:巴克莱:维持Snap"超配"评级,目标价从15美元升至16美元;Canaccord Genuity:维持阿梅雷斯克"买入"评级,目标价从59美元升至62美元
08-05 11:45
Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $378 to $386.
08-04 23:28
华盛资讯8月4日讯,Krystal Biotech公布2026财年Q2业绩,公司Q2营收1.19亿美元,同比增长24.0%,归母净利润0.55亿美元,同比增长44.7%。
08-04 04:05
华盛资讯8月4日讯,Krystal Biotech公布2026财年Q2业绩,公司Q2营收1.19亿美元,同比增长24.1%,归母净利润0.55亿美元,同比增长42.9%。
08-04 02:17